LY294002 evidently reduced the phosphorylation of PI3K/Akt in CML cells resistant to IM with up-regulated HDAC2, while the over-expression of HDAC2 was not blocked through LY294002. The gene discussed is AKT1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.